CIPLA LTD vs SANOFI CONS HEALTHC IND L

A side-by-side comparison of CIPLA LTD (CIPLA) and SANOFI CONS HEALTHC IND L (SANOFICONR) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

CIPLA LTD and SANOFI CONS HEALTHC IND L are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

29.54
P/E ratio
43.81
3.42
P/B ratio
27.04
0.90%
Dividend yield
1.66%
₹48.02
EPS
₹104.25

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

11.60%
Return on equity
71.60%
15.00%
Return on capital
90.00%
21.00%
EBITDA margin
35.00%
13.71%
Net margin
27.33%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.37%
Revenue CAGR (3Y)
7.40%
10.88%
Profit CAGR (3Y)
9.88%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.15L Cr
Market cap
₹10,514 Cr
₹28,163 Cr
Revenue
₹878 Cr
₹3,862 Cr
Net profit
₹240 Cr
0.02
Debt / equity
0.07
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
SANOFI CONS HEALTHC IND L
  • + ["Company is almost debt free.", "Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 77.6%", "Company has been maintaining a healthy dividend payout of 49.3%"]
  • ["Stock is trading at 27.4 times its book value"]
CIPLA LTD full analysis SANOFI CONS HEALTHC IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

CIPLA LTD vs SANOFI CONS HEALTHC IND L: Share Price, Valuation & Which to Buy | DocStoX